Neurogene Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Neurogene amended its consulting agreement with Stuart Cobb Consulting Ltd., effective April 17, 2026. Monthly consulting fees set at $39,183.33 (≈$470K annualized) commencing January 2026, payable in arrears. Agreement term extended through December 31, 2026, with potential further extension by mutual written consent. No prior fee amount disclosed for comparison.
Why this rating
Routine consulting contract amendment. ~$470K annualized fee is ~0.3% of $146M market cap—immaterial. Standard administrative action, no operational or strategic change disclosed.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.